Study to Evaluate the Safety and Pharmacokinetics of CKD-379

Clinical trial NCT05952219 · UNKNOWN

Trial details

NCT number: NCT05952219
Sponsor: Chong Kun Dang Pharmaceutical
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Type II Diabetes Mellitus

Start date: 2023-06-02
Primary completion: 2023-06-19
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.